Finance

Lists
Why is VIR down १७.८२%?
Dive Deeper
VIR:NASDAQ
Vir Biotechnology Inc
US$ ९.९६
-१७.८२%
(-२.१६) 1D
नोभेम्बर १३, १६:००:०० GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VIR...
Open
US$ १०.४६
High
US$ १०.७०
Low
US$ ९.७१
Mkt. cap
१.७१ अरब
Avg. vol.
२०.६४ लाख
Volume
१.६७ करोड
52-wk high
US$ १४.३८
52-wk low
US$ ५.३२
EPS
-US$ १.२६
Beta
१.७०
Shares outstanding
१७.१३ करोड
No. of employees
३६७
Open
US$ १०.४६
High
US$ १०.७०
Low
US$ ९.७१
Mkt. cap
१.७१ अरब
Avg. vol.
२०.६४ लाख
Volume
१.६७ करोड
52-wk high
US$ १४.३८
52-wk low
US$ ५.३२
EPS
-US$ १.२६
Beta
१.७०
Shares outstanding
१७.१३ करोड
No. of employees
३६७
News stories
From web sources and news partners
About Vir Biotechnology Inc
CEOMarianne De Backer
Employees३६७
Founded२०१६ अप्रिल ७
Headquartersसान फ्रान्सिस्को, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websitevir.bio
Analyst ratings
Based on 8 analysts giving stock ratings to VIR in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for VIR in the last 3 months.
Highest
Current US$ ९.९६
US$ ३०.०० (+२०१.२०%)
Average
US$ २२.४३ (+१२५.२०%)
Lowest
US$ १७.०० (+७०.६८%)
Analyst
Recommendation
Action
Price target
Projected
Date
Etzer Darout
Barclays
Buy
Maintained
US$ ३०.००
+२०१.२%
11/11/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
US$ २५.००
+१५१%
11/10/2026
Michael Ulz
Morgan Stanley
Buy
Reiterated
US$ २८.००
+१८१.१%
11/10/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
US$ २२.००
+१२०.९%
11/10/2026
Alec Stranahan
Bank of America Securities
Buy
Reiterated
US$ १७.००
+७०.७%
11/06/2026
Roanna Ruiz
Leerink Partners
Buy
Reiterated
US$ १७.००
+७०.७%
11/05/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
11/05/2026
Joseph Stringer
Needham
Buy
Maintained
US$ १८.००
+८०.७%
09/28/2026
Paul Choi
Goldman Sachs
Buy
Maintained
US$ २१.००
+११०.८%
05/06/2026
Sean McCutcheon
Raymond James
Buy
Maintained
US$ १९.००
+९०.८%
02/24/2026
Last report
२०२६ नोभेम्बर ४
Fiscal period
Q3 2026
-US$ ०.५७ / -US$ ०.७५
+२३.५१%beat
Revenue / Est. (USD)
-१.८८ लाख / १३.८० लाख
-११३.६२%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
६.४१ करोड
-२९.०० हजार
२३.८९ करोड
-१.८८ लाख
Cost of goods sold
८.८५ करोड
१०.९८ करोड
१३.५३ करोड
८.०० करोड
Cost of revenue
८.८५ करोड
१०.९८ करोड
१३.५३ करोड
८.०० करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.३६ करोड
२.३३ करोड
३.०२ करोड
२.४४ करोड
Operating expense
२.३६ करोड
२.३३ करोड
३.०२ करोड
२.४४ करोड
Total operating expenses
११.२१ करोड
१३.३२ करोड
१६.५५ करोड
१०.४५ करोड
Operating income
-४.८० करोड
-१३.३२ करोड
७.३५ करोड
-१०.४७ करोड
Other non operating income
-३.३५ लाख
-२.५४ लाख
-४.५१ लाख
-६.५१ लाख
EBT including unusual items
-४.३१ करोड
-१२.५५ करोड
८.०३ करोड
-९.६४ करोड
EBT excluding unusual items
-४.०५ करोड
-१२.६२ करोड
८.२० करोड
-९.६० करोड
Income tax expense
-१.३७ लाख
१.७० लाख
१.७९ लाख
-१.४३ लाख
Effective tax rate
०.३२%
-०.१४%
०.२२%
०.१५%
Other operating expenses
-
-
-
-
Net income
-४.२९ करोड
-१२.५७ करोड
८.०१ करोड
-९.६३ करोड
Net profit margin
-६६.९९%
४,३३,४३१.०३%
३३.५१%
५१,१९७.८७%
Earnings per share
-०.३१
-०.८५
०.४७
-०.५७
Interest and investment income
७८.०२ लाख
७१.८९ लाख
८९.६६ लाख
९३.२३ लाख
Interest expense
-
-
-
-
Net interest expenses
७८.०२ लाख
७१.८९ लाख
८९.६६ लाख
९३.२३ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-४.५१ करोड
-१३.०४ करोड
७.६३ करोड
-१०.१९ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू